Colorectal cancer risk after colonoscopy in elderly diabetes patient and men
Colorectal cancer risk after colonoscopy in elderly diabetes patient and men
批准号:
7785904
负责人:
YU-XIAO YANG
金额:
$42.72万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2012-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Provided by Applicant): Colorectal cancer (CRC) is the second leading cause of cancer death in the U.S. Colonoscopy is widely used to screen for CRC. Current guidelines recommend screening colonoscopy once every 10 years in average risk patients over >50 year who have no polyps identified at colonoscopy (i.e., negative colonoscopy). However, the prevalence of CRC and polyps increase with age. In addition, nearly 1/4 of the U.S. population over 60 years of age have diabetes mellitus (DM). Recent data suggest patients with diabetes mellitus (DM) have an increased risk of CRC. Furthermore, population-based cancer incidence data have consistently suggested a higher incidence of CRC among men vs. women, and the disparity is most striking among those >65 years. Hence, the negative predictive value of a negative colonoscopy may be lower in patients >65 years who are male or have DM. As a result, there is uncertainty whether the recommended 10-year interval between screening colonoscopies in whom no polyps were identified should apply to elderly men or elderly DM patients. We hypothesize that among patients over the age of 65, the risk of CRC following a negative colonoscopy is higher in men vs. women, and in DM patients vs. non-DM patients. To test this hypothesis, we have designed a population-based cohort study using the linked SEERMedicare
data. The study will determine among the SEER-Medicare population, 1) whether men who have
undergone a negative colonoscopy have a higher subsequent incidence of CRC than women with a
negative colonoscopy; 2) whether DM patients who have undergone a negative colonoscopy have a higher subsequent incidence of CRC than non-DM patients with a negative colonoscopy; 3) whether men or DM patients who have undergone a negative colonoscopy have a lower incidence of CRC than the general SEER-Medicare population who have not undergone colonoscopy and whether the lower incidence persists for up to 10 years; 4) determine the absolute incidence by time of CRC following a colonoscopy without polyps for men, women, all patients with diabetes, men with diabetes, and women with diabetes. Both relative and absolute risks will be examined during the follow-up period. Subgroup analysis will examine the risk for proximal colon cancer and the combined effect of male sex and DM.
Relevance to Public Health: CRC is a common cause of death among the elderly population. Screening for colorectal cancer can reduce the risk of cancer and cancer-related mortality. Given the increased incidence of CRC in elderly male patients or elderly DM patients, it is important to determine whether the recommended 10-year interval between colonoscopies without polyps offers adequate protection to these high risk groups. Our study will help establish the appropriate time interval for elderly men and elderly DM patients to undergo a second colonoscopy following a negative colonoscopy so that they will not be facing an unacceptably high rate of preventable CRC morbidity and mortality.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Comparative Effectiveness of Split-dose Colonoscopy Bowel Preparation Regimens
-
批准号:10216343
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:YU-XIAO YANG
-
依托单位:
Comparative Effectiveness of Split-dose Colonoscopy Bowel Preparation Regimens
-
批准号:9293611
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:YU-XIAO YANG
-
依托单位:
Comparative Effectiveness of Split-dose Colonoscopy Bowel Preparation Regimens
-
批准号:9600613
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:YU-XIAO YANG
-
依托单位:
Comparative Effectiveness of Split-dose Colonoscopy Bowel Preparation Regimens
-
批准号:10201717
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:YU-XIAO YANG
-
依托单位:
The Effect of Exogenous Insulin Therapy on Colorectal Adenoma Risk among PTS
-
批准号:8046051
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:YU-XIAO YANG
-
依托单位:
The Effect of Exogenous Insulin Therapy on Colorectal Adenoma Risk among PTS
-
批准号:8586854
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:YU-XIAO YANG
-
依托单位:
The Effect of Exogenous Insulin Therapy on Colorectal Adenoma Risk among PTS
-
批准号:8390430
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:YU-XIAO YANG
-
依托单位:
Effect of Chronic Proton Pump Inhibitor Therapy on Bone Mineral Density and Bone
-
批准号:8527717
-
项目类别:
-
资助金额:$52.04万
-
财政年份:2009
-
负责人:YU-XIAO YANG
-
依托单位:
Effect of Chronic Proton Pump Inhibitor Therapy on Bone Mineral Density and Bone
-
批准号:7784005
-
项目类别:
-
资助金额:$61.51万
-
财政年份:2009
-
负责人:YU-XIAO YANG
-
依托单位:
Colorectal cancer risk after colonoscopy in elderly diabetes patient and men
-
批准号:8118428
-
项目类别:
-
资助金额:$43.84万
-
财政年份:2009
-
负责人:YU-XIAO YANG
-
依托单位:
Effect of Chronic Proton Pump Inhibitor Therapy on Bone Mineral Density and Bone
-
批准号:8123411
-
项目类别:
-
资助金额:$58.73万
-
财政年份:2009
-
负责人:YU-XIAO YANG
-
依托单位:
Effect of Chronic Proton Pump Inhibitor Therapy on Bone Mineral Density and Bone
-
批准号:8324496
-
项目类别:
-
资助金额:$59.48万
-
财政年份:2009
-
负责人:YU-XIAO YANG
-
依托单位:
Colorectal cancer risk after colonoscopy in elderly diabetes patient and men
-
批准号:7942001
-
项目类别:
-
资助金额:$42.65万
-
财政年份:2009
-
负责人:YU-XIAO YANG
-
依托单位:
Effect of Chronic Proton Pump Inhibitor Therapy on Bone Mineral Density and Bone
-
批准号:7941768
-
项目类别:
-
资助金额:$63.25万
-
财政年份:2009
-
负责人:YU-XIAO YANG
-
依托单位:
Colon Cancer Risk Modification by PPI and HRI Therapy
-
批准号:6681773
-
项目类别:
-
资助金额:$13.25万
-
财政年份:2003
-
负责人:YU-XIAO YANG
-
依托单位:
Colon Cancer Risk Modification by PPI and HRI Therapy
-
批准号:6804962
-
项目类别:
-
资助金额:$13.25万
-
财政年份:2003
-
负责人:YU-XIAO YANG
-
依托单位:
Colon Cancer Risk Modification by PPI and HRI Therapy
-
批准号:7253098
-
项目类别:
-
资助金额:$13.25万
-
财政年份:2003
-
负责人:YU-XIAO YANG
-
依托单位:
Colon Cancer Risk Modification by PPI and HRI Therapy
-
批准号:6921970
-
项目类别:
-
资助金额:$13.35万
-
财政年份:2003
-
负责人:YU-XIAO YANG
-
依托单位:
Colon Cancer Risk Modification by PPI and HRI Therapy
-
批准号:7114258
-
项目类别:
-
资助金额:$13.25万
-
财政年份:2003
-
负责人:YU-XIAO YANG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
脊髓电刺激活化Na(V)1.1阳性GABA神经元持续缓解癌痛
-
批准号:82371223
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:闻大翔
-
依托单位:
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
-
批准号:82372743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈卓佳
-
依托单位:
丁酸梭菌代谢物(如丁酸、苯乳酸)通过MYC-TYMS信号轴影响结直肠癌化疗敏感性的效应及其机制研究
-
批准号:82373139
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:李孟鸿
-
依托单位:
均相液相生物芯片检测系统的构建及其在癌症早期诊断上的应用
-
批准号:82372089
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:李万万
-
依托单位:
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
-
批准号:82373145
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:历鹏
-
依托单位:
基于密度泛函理论金原子簇放射性药物设计、制备及其在肺癌诊疗中的应用研究
-
批准号:82371997
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张春富
-
依托单位:
BRPF1 m6A修饰异常通过重塑BCAT1超级增强子介导Setd2缺陷型肾癌支链氨基酸代谢成瘾的机制研究
-
批准号:82372724
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:何竑超
-
依托单位:
基于影像代谢重塑可视化的延胡索酸水合酶缺陷型肾癌危险性分层模型的研究
-
批准号:82371912
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:吴广宇
-
依托单位:
EGFR通过激活β-catenin重塑肿瘤微环境代谢调控肿瘤免疫逃逸的分子机制研究
-
批准号:32100574
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:邵飞
-
依托单位:
脯氨酸羟化酶EglN1转位到线粒体介导乳腺癌细胞适应缺氧应激的机制研究
-
批准号:32100570
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:闫朝君
-
依托单位: